Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping […]

4th Covalent Drug Discovery & Development Summit (October 20–22, Boston, MA) Covalent drug discovery is entering a defining era. Once constrained by safety and selectivity concerns, advances in chemistry, screening […]